Online citations, reference lists, and bibliographies.

Predicting Concentrations Of Trace Organic Compounds In Municipal Wastewater Treatment Plant Sludge And Biosolids Using The PhATE™ Model.

Virginia L. Cunningham, Vincent J D'Aco, Danielle Pfeiffer, Paul D. Anderson, Mary E Buzby, Robert E. Hannah, James Jahnke, Neil J. Parke
Published 2012 · Medicine, Engineering
Cite This
Download PDF
Analyze on Scholarcy
Share
This article presents the capability expansion of the PhATE™ (pharmaceutical assessment and transport evaluation) model to predict concentrations of trace organics in sludges and biosolids from municipal wastewater treatment plants (WWTPs). PhATE was originally developed as an empirical model to estimate potential concentrations of active pharmaceutical ingredients (APIs) in US surface and drinking waters that could result from patient use of medicines. However, many compounds, including pharmaceuticals, are not completely transformed in WWTPs and remain in biosolids that may be applied to land as a soil amendment. This practice leads to concerns about potential exposures of people who may come into contact with amended soils and also about potential effects to plants and animals living in or contacting such soils. The model estimates the mass of API in WWTP influent based on the population served, the API per capita use, and the potential loss of the compound associated with human use (e.g., metabolism). The mass of API on the treated biosolids is then estimated based on partitioning to primary and secondary solids, potential loss due to biodegradation in secondary treatment (e.g., activated sludge), and potential loss during sludge treatment (e.g., aerobic digestion, anaerobic digestion, composting). Simulations using 2 surrogate compounds show that predicted environmental concentrations (PECs) generated by PhATE are in very good agreement with measured concentrations, i.e., well within 1 order of magnitude. Model simulations were then carried out for 18 APIs representing a broad range of chemical and use characteristics. These simulations yielded 4 categories of results: 1) PECs are in good agreement with measured data for 9 compounds with high analytical detection frequencies, 2) PECs are greater than measured data for 3 compounds with high analytical detection frequencies, possibly as a result of as yet unidentified depletion mechanisms, 3) PECs are less than analytical reporting limits for 5 compounds with low analytical detection frequencies, and 4) the PEC is greater than the analytical method reporting limit for 1 compound with a low analytical detection frequency, possibly again as a result of insufficient depletion data. Overall, these results demonstrate that PhATE has the potential to be a very useful tool in the evaluation of APIs in biosolids. Possible applications include: prioritizing APIs for assessment even in the absence of analytical methods; evaluating sludge processing scenarios to explore potential mitigation approaches; using in risk assessments; and developing realistic nationwide concentrations, because PECs can be represented as a cumulative probability distribution. Finally, comparison of PECs to measured concentrations can also be used to identify the need for fate studies of compounds of interest in biosolids.
This paper references
10.1016/j.chroma.2008.01.063
Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway.
T. Vasskog (2008)
10.1002/etc.5620210702
Fate and effects of triclosan in activated sludge.
T. Federle (2002)
10.1016/j.watres.2009.03.004
Detection of the antimicrobials triclocarban and triclosan in agricultural soils following land application of municipal biosolids.
Jongmun Cha (2009)
10.1016/j.yrtph.2009.10.006
Human health risk assessment of carbamazepine in surface waters of North America and Europe.
Virginia L. Cunningham (2010)
10.1039/b909311g
Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany.
Marco Scheurer (2009)
10.1016/j.watres.2005.05.031
Removal of pharmaceuticals and fragrances in biological wastewater treatment.
A. Joss (2005)
10.1016/j.yrtph.2005.05.005
Human pharmaceuticals in US surface waters: a human health risk assessment.
B. Schwab (2005)
10.1016/S0048-9697(98)00339-8
Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil.
M. Stumpf (1999)
10.2166/wst.2006.357
Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan.
M. Yasojima (2006)
10.2166/wst.2004.0335
Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment.
N. Paxéus (2004)
10.1002/etc.5620220404
Anaerobic degradation of linear alkylbenzene sulfonate.
Anders Skibsted Mogensen (2003)
10.1007/BF00561804
Cross-over study of ten tetracycline preparations
J. Tuomisto (1973)
10.1016/j.watres.2010.07.051
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
Evelyn Walters (2010)
10.1897/IEAM_2009-070.1
Probabilistic application of a fugacity model to predict triclosan fate during wastewater treatment.
Michael J. Bock (2010)
10.1007/BF01061403
The bioavailability of sixteen tetracycline products
Marvin C. Meyer (1974)
10.1016/J.WATRES.2007.07.031
Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China.
Anna Gulkowska (2008)
10.1016/S0048-9697(98)00336-2
Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands.
A. Belfroid (1999)
10.1021/es0516211
Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge.
Richard H. Lindberg (2006)
10.1021/es0603406
Survey of organic wastewater contaminants in biosolids destined for land application.
Chad A. Kinney (2006)
10.1002/etc.5620210701
Measurement of triclosan in wastewater treatment systems.
D. Mcavoy (2002)
10.1002/etc.66
Triclocarban, triclosan, polybrominated diphenyl ethers, and 4-nonylphenol in biosolids and in soil receiving 33-year biosolids application.
Kang Xia (2010)
10.1126/science.263.5147.641
Verification, Validation, and Confirmation of Numerical Models in the Earth Sciences
N. Oreskes (1994)
10.1002/etc.5620120604
Fate of linear alkylbenzene sulfonate in the environment
D. Mcavoy (1993)
10.1016/j.envint.2010.06.004
Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids.
Bradley O Clarke (2011)
10.1021/es9707973
Identification of Estrogenic Chemicals in STW Effluent. 1. Chemical Fractionation and in Vitro Biological Screening
C. Desbrow (1998)
10.1016/j.chemosphere.2006.07.047
Modeling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers.
P. F. Robinson (2007)
10.1007/BF01060035
Effect of altered urinarypH on tetracycline and doxycycline excretion in humans
James M. Jaffe (2005)
10.1016/j.scitotenv.2006.07.039
Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies.
Anke Göbel (2007)
10.1016/j.yrtph.2008.10.006
Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
V. Cunningham (2009)
10.1021/es0264448
Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil.
E. M. Golet (2003)
10.1002/cpt197213197
Assessment of the biologic availability of tetracycline products in man.
William H. Barr (1972)
10.1897/08-622.1
Exposure assessment of 17alpha-ethinylestradiol in surface waters of the United States and Europe.
R. Hannah (2009)
10.1016/j.watres.2006.02.014
Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme.
A. Joss (2006)
10.1289/ehp.0900654
An Assessment of Potential Exposure and Risk from Estrogens in Drinking Water
Daniel J Caldwell (2010)
10.1016/j.scitotenv.2008.06.038
Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
K. Choi (2008)
10.1016/j.watres.2008.11.043
Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
J. Radjenovic (2009)
10.1016/0045-6535(95)00003-Q
AIS/CESIO Environmental Surfactant Monitoring Programme. Part 1: LAS Monitoring study in "de Meern" sewage treatment plant and receiving river "Leidsche Rijn".
T. Feijtel (1995)
10.1098/rsta.2009.0154
Organic contaminants in sewage sludge (biosolids) and their significance for agricultural recycling
Stephen R. Smith (2009)
10.1021/es034430b
Screening analysis of human pharmaceutical compounds in U.S. surface waters.
Paul D. Anderson (2004)
10.1016/j.chemosphere.2009.10.043
Fate of triclosan in agricultural soils after biosolid applications.
Núria Lozano (2010)
10.1592/phco.21.17.1436.34434
Possible interaction between intravenous azithromycin and oral cyclosporine.
Robert L. Page (2001)
10.1016/j.scitotenv.2008.03.003
Occurrence and fate of emerging wastewater contaminants in Western Balkan Region.
Senka Terzic (2008)
Pharmacotherapeutics of macrolides, lincomycins, and spectinomycin.
G. Burrows (1980)
10.2166/wst.2004.0306
Combined chemical analyses and biomonitoring at Avedoere wastewater treatment plant in 2002.
B. Jacobsen (2004)
10.1021/es050991m
Removal of pharmaceuticals in sewage treatment plants in Italy.
S. Castiglioni (2006)



This paper is referenced by
10.1039/C2EM30640A
Potential environmental implications of nano-enabled medical applications: critical review.
Indrani Mahapatra (2013)
10.1002/etc.3233
Prioritizing human pharmaceuticals for ecological risks in the freshwater environment of Korea.
Kyunghee Ji (2016)
10.1016/j.scitotenv.2015.09.100
Risk assessment of down-the-drain chemicals at large spatial scales: Model development and application to contaminants originating from urban areas in the Saint Lawrence River Basin.
Günther Grill (2016)
10.1007/698_2015_5017
Fate and Degradation of Emerging Contaminants in Rivers: Review of Existing Models
J. Aldekoa (2015)
Modelling the Fate of Xenobiotic Trace Chemicals via Wastewater Treatment and Agricultural Resource Reuse
Fabio Polesel (2016)
Environmental risk assessment and human pharmaceuticals : limitations and future improvements
Samantha Walker (2012)
10.1002/ieam.1311
Landfill disposal of unused medicines reduces surface water releases.
Lial Tischler (2013)
Environmental Fate of Low Vapor Pressure – Volatile Organic Compounds from Consumer Products : A Modeling Approach
Hyeong-Moo Shin (2015)
10.1016/j.watres.2018.08.053
Estimating the eco-toxicological risk of estrogens in China's rivers using a high-resolution contaminant fate model.
Günther Grill (2018)
Optimization of Sewage Sludge Composting: Problems and Solutions. Reoveesette kompostimistehnoloogiate optimeerimine ravimijääkide kahjutustamise eesmärgil
L Nei (2017)
10.1016/j.scitotenv.2015.08.108
Pharmaceuticals and personal care products in untreated and treated sewage sludge: Occurrence and environmental risk in the case of application on soil - A critical review.
Paola Verlicchi (2015)
10.1002/ieam.1793
iSTREEM(®) : An approach for broad-scale in-stream exposure assessment of "down-the-drain" chemicals.
Katherine E. Kapo (2016)
Characterization and Modeling of Selected Antiandrogens and Pharmaceuticals in Highly Impacted Reaches of Grand River Watershed in Southern Ontario
Maricor J. Arlos (2013)
Environmental Fate of Low Vapor Pressure - Volatile Organic Compounds from Consumer Products: A Modeling Approach
Deborah H Bennett (2015)
10.1016/j.chemosphere.2018.10.038
Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
D. Caldwell (2019)
10.1016/j.chemosphere.2018.10.036
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.
J. O. Straub (2019)
Semantic Scholar Logo Some data provided by SemanticScholar